福利在线免费

iFOOT

Intelligent Foot Offloading Insole Technology (iFOOT)

Identifier: KD01AGX

The Invention

Diabetic foot ulceration and amputation are a worldwide concern, including Malta where more than 500 amputations are carried out annually. In EU, 450,000 amputations cost 2.5 billion yearly, major economic consequences for patients and healthcare systems. These are preventable if managed timely. Current management is clearly not effective, as can be seen by the huge number of amputations, clearly demonstrating the need for new and effective technologies to be implemented.

 

iFOOT - "intelligent Foot Offloading Orthoses Technology" is an intelligent insole capable of altering its shape according to sensor readings of gait parameters to offload areas of the foot at high risk of ulceration in diabetes. An Artificial Intelligence algorithm analyses and processes data from these sensors embedded in the insole to identify areas at high risk of ulceration. This type of offloading device will offer a solution to patients requiring biomechanical intervention which, to-date, is not effective as testified by the large number of amputations carried out worldwide every year.

 

Novelty 

Latest state of the art, i.e. 鈥淪mart insoles鈥 presently only measure pressure, through pressure sensors, and the number of steps taken by the user through accelerometery. iFOOT goes beyond all the above by not only reporting sensor readings to the user and clinician, but also produces a risk assessment of the area likely to ulcerate. The device then changes shape through innovative electro-mechanical actuation methods to offload these areas of high risk. Therefore iFOOT: 

  • Analyses gait data in real time during walking 
  • Learns and reacts to postural changes in various real-life situations 
  • Changes shape through electro-mechanical activation of regions, controlled by a micro-controller that determines the optimum shape to be adopted through an intelligent algorithm

 

Applications / Industries

The main use of the technology is for diabetic patients to prevent amputations of the foots. Other applications include the use of the smart insole in rheumatology, in the management, treatment and prevention of foot musculoskeletal conditions in sports, and in sports footwear manufacture.

 

Development status

The first prototype has been finalised and fitted in a diabetic shoe. The forefoot regions of activation have been statically tested to 95kg, with no harmful effects occurring to either tester or device. The team are now in the process of enhancing their test base. 

 

Intellectual Property Status

The technology contains proprietary solution and components that are being considered for patenting.

 

Team 

Prof. Alfred Gatt

Prof. Cynthia Formosa 

Interested?
Contact Mr. Andr谩s Havasi or the Knowledge Transfer Office

 



/knowledgetransfer/technologies/health-biotech/activefootoffloadinginsole